Pharmacokinetic (PK) and tumor samples obtained from study participants further validate our in vitro findings that NUC-7738 is an effective proapoptotic agent in cancer cells with additional effects on the NF-κB pathway. The gene discussed is NFKB1; the disease is neoplasm.